| 1. |
Management of depression in elderly needs improvement |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1303KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 2. |
Milnacipran moves in on major depression |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 3-4
Wayne Elwood,
Preview
|
PDF (2303KB)
|
|
摘要:
Tolerability and efficacy are important factors affecting the clinical choice of an antidepressant agent. Currently available agents such as the tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) have some shortcomings and there may be a need for a new alternative which combines good clinical efficacy with a benign tolerability profile. At the 10th Congress of the European College of Neuropsychopharmacology [Vienna, Austria; September 1997] delegates at a Pierre Fabre-sponsored symposium were told that milnacipran is a novel antidepressant which could fit this therapeutic niche.
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 3. |
Managing patients with diabetes mellitus and retinopathy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 4-4
&NA;,
Preview
|
PDF (1187KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 5-6
&NA;,
Preview
|
PDF (2215KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 5. |
Menopausal women willing to pay large sums for HRT |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 6-6
&NA;,
Preview
|
PDF (1138KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 6. |
Rituximab effective in non-Hodgkin's lymphoma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 7-7
&NA;,
Preview
|
PDF (1011KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 7. |
Immunotherapy for any cancer? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 8-8
&NA;,
Preview
|
PDF (1142KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 8. |
New options to reduce NSAID-associated GI toxicity |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 9-9
Gill Higgins,
Preview
|
PDF (1140KB)
|
|
摘要:
A new group of compounds called the nitro-NSAIDs aroused a great deal of interest at the 6th United European Gastroenterology Week [Birmingham, UK; October 1997]. Initial studies indicate that these drugs retain the anti-inflammatory and antithrombotic properties of conventional NSAIDs, while being associated with less GI toxicity. If their development is successful, they will compete with the highly-selective cyclo-oxygenase 2 (COX-2) inhibitors, which are also being promoted as a better tolerated alternative to conventional NSAIDs. Two COX-2 inhibitors are currently in phase III clinical trials.
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 9. |
News from the 27th Annual Meeting of the Society for NeuroscienceNew Orleans, US October 1997 |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1182KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 10. |
2-year data on BP and tolerability from the HOT study |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1112,
1997,
Page 11-11
&NA;,
Preview
|
PDF (1010KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
